EUVIMEDEUVIMED entdecken
Crossref

Unraveling Diabetic Cardiomyopathy (DCM): The Critical Role of the Yap–miR-22-3p–Sirt1 Axis in the Pathogenesis of DCM

Yilang Li, Yue Zeng, Yuling Lian, Chi Zhang, Xiaoqing Chen, Siyu Zhang, Yipu Huang, Wenchang Yuan, Yuan Qin, Ducai Liu, Yun Liu, Yilin Chen und 3 weitere

Diabetes · 01.06.2026 · 75 (6) · 974-990

DOI: 10.2337/db25-0435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, online erschienen am 02.03.2026. Verfasst von Yilang Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target and Clinical Pharmacology, NMPA and State Key Laboratory of Respirato…. Hauptthemen laut MEDLINE: MicroRNAs, Diabetic Cardiomyopathies, Sirtuin 1, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Special Projects in Key Fields of Ordinary Colleges and Universities in Guangdong Province, Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic cardiomyopathy (DCM), characterized by myocardial hypertrophy and fibrosis, is a severe complication of diabetes. Activation of Yes-associated protein (Yap) has been implicated in myocardial remodeling and cardiac dysfunction. This study aimed to elucidate the role and underlying molecular mechanisms of Yap in DCM. Yap expression was evaluated in mice with type 2 diabetes mellitus (T2DM) and in neonatal rat cardiomyocytes (NRCMs) treated with high glucose (HG) or HG + palmitic acid (PA). Adeno-associated virus transfection, adenovirus infection, and a transgenic mouse model were used to modulate Yap expression both in vivo and in vitro. RNA sequencing and miRNA sequencing were used to identify Yap’s downstream targets and related mechanisms. Functional assays, including assessment of molecular markers, cell morphology, and echocardiography, were conducted to evaluate cardiomyocyte hypertrophy and fibrosis. Results showed that Yap expression was elevated in HG or HG+PA-treated NRCMs and hearts of T2DM mice, promoting myocardial hypertrophy and fibrosis. Inhibition of Yap reduced cardiomyocyte cross-sectional area, collagen deposition, and levels of hypertrophy markers atrial natriuretic peptide and β-myosin heavy chain. RNA sequencing identified Sirt1 as a downstream target of Yap. Bioinformatics analysis indicated that Yap positively regulated miR-22-3p, which in turn inhibited Sirt1. Yap inhibition increased Sirt1 expression, alleviating myocardial remodeling. Conversely, Sirt1 knockdown reversed the protective effects of Yap inhibition, exacerbating hypertrophy and fibrosis. In conclusion, Yap promotes the progression of DCM by upregulating miR-22-3p expression and suppressing Sirt1 expression. Therapeutically targeting the newly identified Yap–miR-22-3p–Sirt1 axis could mitigate multiple aspects of diabetic cardiac remodeling. Article Highlights Diabetic cardiomyopathy (DCM) describes the abnormality of myocardial structure and function caused by diabetes, and Yes-associated protein (Yap) is linked to various cardiovascular diseases, modulating remodeling and cardiac function in hearts, but its role in DCM is unclear. How Yap affects myocardial structure and function in mice with type 2 diabetes mellitus and the underlying pathways were investigated. High glucose or high glucose plus palmitic acid levels enhance Yap activity, thereby promoting miR-22-3p expression and inhibiting sirtuin 1 (Sirt1) expression. The Yap–miR-22-3p–Sirt1 axis plays critical roles in the cause of DCM. The molecular pathways investigated offer promising targets for therapeutic intervention against DCM and provide new insights into the development of innovative treatment strategies to combat cardiac dysfunction in patients with diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDiabetic CardiomyopathiesSirtuin 1Adaptor Proteins, Signal TransducingAnimalsMiceRatsMyocytes, CardiacYAP-Signaling ProteinsMaleDiabetes Mellitus, Type 2Mice, TransgenicFibrosisMice, Inbred C57BLDiabetes Mellitus, Experimental

Substanzen

MicroRNAsSirtuin 1Yap1 protein, mouseYAP-Signaling ProteinsMirn22 microRNA, mouseAdaptor Proteins, Signal TransducingSirt1 protein, mouseMIRN22 microRNA, rat

Autor:innen und Institutionen

  • Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target and Clinical Pharmacology, NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical Unive…
  • The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.

ORCID-Profile: Xun Yuan, Ning Hou

Förderung

  • Special Projects in Key Fields of Ordinary Colleges and Universities in Guangdong Province
  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Li, Y., Zeng, Y., Lian, Y., Zhang, C., Chen, X., Zhang, S., Huang, Y., Yuan, W., Qin, Y., Liu, D., Liu, Y., Chen, Y., Shi, Y., Yuan, X., & Hou, N. (2026). Unraveling Diabetic Cardiomyopathy (DCM): The Critical Role of the Yap–miR-22-3p–Sirt1 Axis in the Pathogenesis of DCM. Diabetes, 75(6), 974-990. https://doi.org/10.2337/db25-0435

Vancouver

Li Y, Zeng Y, Lian Y, Zhang C, Chen X, Zhang S, et al. Unraveling Diabetic Cardiomyopathy (DCM): The Critical Role of the Yap–miR-22-3p–Sirt1 Axis in the Pathogenesis of DCM. Diabetes. 2026;75(6):974-990. doi:10.2337/db25-0435

BibTeX
@article{Li2026,
  author = {Li, Yilang and Zeng, Yue and Lian, Yuling and Zhang, Chi and Chen, Xiaoqing and Zhang, Siyu and Huang, Yipu and Yuan, Wenchang and Qin, Yuan and Liu, Ducai and Liu, Yun and Chen, Yilin and Shi, Yongying and Yuan, Xun and Hou, Ning},
  title = {Unraveling Diabetic Cardiomyopathy (DCM): The Critical Role of the Yap–miR-22-3p–Sirt1 Axis in the Pathogenesis of DCM},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {6},
  pages = {974--990},
  doi = {10.2337/db25-0435}
}
Kostenlos starten →